Sorafenib induces paradoxical phosphorylation of the extracellular signal-regulated kinase pathway in acute myeloid leukemia cells lacking FLT3-ITD mutation
Fariba Fouladi(Philipps University of Marburg), Andreas Neubauer(RWTH Aachen University), Florian Hub(Philipps University of Marburg), Cornelia Brendel(Philipps University of Marburg), Lutz B. Jehn(Philipps University of Marburg), Thorsten Stiewe(Philipps University of Marburg), Katharina Henkenius, Andreas Burchert(Philipps University of Marburg), Stephan Metzelder(Philipps University of Marburg)
Cited by 6
Related Papers
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.4k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)
|Journal of Clinical Oncology|2005|573